Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
Is a |
ethanolaminoleat |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiallergikum |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine derivative antihistamine |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine oleate (substance) |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Histamine receptor antagonist |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cardiovascular agent (substance) |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|